Hard-Med Pharmaceutical has experienced consistent and robust growth in its annual turnover throughout the years, positioning itself as a prominent player in the pharmaceutical industry. Beginning in 2018, the company witnessed a substantial increase in sales, with figures rising from 5,968,672 USD to 7,458,247 USD, marking an impressive growth rate of 25%. This upward trajectory continued in 2019, as sales soared to 9,343,971 USD, representing another noteworthy 25% increase from the previous year. The company's commitment to excellence and customer satisfaction played a pivotal role in achieving these exceptional results.

​

Building on its previous successes, Hard-Med Pharmaceutical achieved remarkable growth in 2020, with sales surging by an astonishing 45% to reach 13,528,927 USD. This substantial increase can be attributed to several key factors, including the company's expansion into new markets, the introduction of innovative product lines, and strategic partnerships with healthcare providers. Additionally, Hard-Med Pharmaceutical's relentless focus on research and development, coupled with its state-of-the-art manufacturing facilities, enabled the company to meet the growing demand for high-quality medications and medical supplies.

​

The year 2021 proved to be another exceptional period for Hard-Med Pharmaceutical, as sales continued to soar to an extraordinary 19,860,926 USD, representing an impressive 47% increase. This remarkable growth was driven by the company's unwavering commitment to meeting the evolving healthcare needs of the Iraqi population. Hard-Med Pharmaceutical's extensive network of suppliers, distributors, and healthcare partners played a crucial role in ensuring the availability and accessibility of its products throughout the country.

​

Looking ahead, Hard-Med Pharmaceutical maintains an optimistic outlook for the future, with projected sales growth of 15% in 2022 and beyond. The company remains dedicated to maintaining its upward trajectory and aims to double its sales by the end of the current year. This ambitious goal is underpinned by the company's unwavering dedication to providing superior healthcare solutions and its continuous investment in cutting-edge technologies and research.

​

Hard-Med Pharmaceutical's exceptional growth can be attributed to its unwavering commitment to quality, innovation, and customer satisfaction. By consistently delivering high-quality medications and medical supplies, the company has earned the trust and loyalty of healthcare professionals and patients across Iraq. As a result, Hard-Med Pharmaceutical has solidified its position as a vital player in the country's healthcare sector, contributing to the overall well-being of the Iraqi population.